ANTIPHONICS IVS: Financial statements 2014
CVR: 35651543
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 34,165 and a net result of DKK -56,878. The profit margin was -166.5%. Equity in the 2014 report amounted to DKK 56,878. The solvency ratio was 96.6%.
- Revenue
- DKK 34,165
- Gross Profit
- DKK -39,378
- Profit/Loss
- DKK -56,878
- Equity
- DKK 56,878
- Total Assets
- DKK 58,856
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of January 16, 2014, Aske Seierup Bode is registered as direktion of ANTIPHONICS IVS.
As of January 16, 2014, Carl Andreas Brixen is registered as direktion of ANTIPHONICS IVS.
ANTIPHONICS IVS was founded on January 16, 2014.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.